# Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.

> **NCT03947567** · PHASE4 · UNKNOWN · sponsor: **Sinocelltech Ltd.** · enrollment: 240 (estimated)

## Conditions studied

- Hemophilia A

## Interventions

- **DRUG:** Recombinant Human Coagulation FVIII

## Key facts

- **NCT ID:** NCT03947567
- **Lead sponsor:** Sinocelltech Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-26
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2020-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03947567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03947567, "Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03947567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*